DKSH, Pfizer ink deal for Cambodia
DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for
DKSH says the new partnership will further strengthen its market position in Southeast Asia while contributing incrementally to the group’s overall earnings and profitability over time.
Earlier, DKSH Healthcare was appointed by Pfizer (Thailand) as |the sole nationwide distributor for all of its pharmaceutical products in Cambodia, effective at the beginning of this year.
“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Cambodia so that more people will benefit from our healthcare innovations,” said Pichitchai Jak-paisan, finance director and Indochina general manager for Pfizer (Thailand).
He said Pfizer chose DKSH as it has a well-established nationwide infrastructure in Cambodia, well-trained local staff and an in-depth understanding of the Cambodian market.
The firm’s expertise in marketing and sales as well as its dedication to compliance and quality will also mean better services to Pfizer’s valued customers and business partners, he added.
